Global S-Amlodipine Market Growth 2024-2030
Similar to levoamlodipine, the global S-amlodipine market is experiencing growth, fueled by the rising incidence of cardiovascular diseases and the need for improved management of
- Bonafide Trust
- 21-08-2024
- Pages : 135
- Figures : 80
- Tables : 153
- Region : Global
- Category : Lifescience & Healthcare
- Healthcare
The global S-amlodipine market is experiencing significant growth, driven by the escalating prevalence of cardiovascular diseases, particularly hypertension and coronary artery disease, which are major contributors to global morbidity and mortality. S-amlodipine, a calcium channel blocker, has established itself as a cornerstone in the management of these conditions. Its mechanism of action involves relaxing blood vessels, thereby reducing blood pressure and improving blood flow to the heart. This therapeutic efficacy has translated into widespread clinical adoption, driving market growth. Furthermore, several factors are converging to propel market expansion. An aging global population, characterized by a higher incidence of cardiovascular diseases, presents a significant and growing patient pool. Rising healthcare expenditure, driven by advancements in medical care and an increased focus on chronic disease management, further fuels market growth. The availability of generic S-amlodipine has significantly enhanced its accessibility and affordability, broadening its reach to a wider patient population. Moreover, continuous advancements in drug delivery systems, such as the development of extended-release formulations, are contributing to market growth. These formulations offer improved patient adherence by reducing the frequency of medication intake, ultimately enhancing treatment outcomes. Hypertension is a common cardiovascular disease affecting a large proportion of the global population. The increasing prevalence of hypertension worldwide is driving the demand for effective antihypertensive drugs such as S-amlodipine.
The global S-Amlodipine market size is projected to grow from US$ 34830 million in 2023 to US$ 75660 million in 2030; it is expected to grow at a CAGR of 11.7% from 2024 to 2030. S AMLODIPINE belongs to a class of medicines called calcium channel blockers which are primarily taken to treat hypertension (high blood pressure) and angina (chest pain). Publisher' newest research report, the “S-Amlodipine Industry Forecast” looks at past sales and reviews total world S-Amlodipine sales in 2023, providing a comprehensive analysis by region and market sector of projected S-Amlodipine sales for 2024 through 2030. With S-Amlodipine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world S-Amlodipine industry. This Insight Report provides a comprehensive analysis of the global S-Amlodipine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on S-Amlodipine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global S-Amlodipine market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for S-Amlodipine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global S-Amlodipine.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleThe global S-amlodipine market exhibits a diverse segmentation based on drug formulation and delivery systems. Immediate-release tablets constitute the most prevalent form, characterized by rapid drug absorption and onset of action. The widespread availability of generic immediate-release formulations has significantly enhanced accessibility and affordability, making them a cornerstone of S-amlodipine therapy. However, the emergence of extended-release formulations has revolutionized S-amlodipine therapy. These innovative formulations, exemplified by S-amlodipine besylate extended-release tablets, are designed to release the medication gradually over an extended period, typically 24 hours. This sustained drug release profile offers several advantages, including the convenience of once-daily dosing, improved patient adherence, and potentially enhanced therapeutic efficacy by maintaining consistent drug levels in the bloodstream. Furthermore, the market encompasses a range of combination therapies, combining S-amlodipine with other antihypertensive agents. Notable examples include S-amlodipine/valsartan and S-amlodipine/hydrochlorothiazide combinations, offering a convenient and effective treatment option for patients requiring multiple medications to manage their hypertension. The judicious selection of S-amlodipine type necessitates a careful consideration of various factors, including the severity of the patient's condition, their individual characteristics, and the specific treatment goals outlined by their physician.
S-amlodipine finds widespread application in the management of various cardiovascular conditions. Hypertension, or high blood pressure, is the primary application area, constituting the largest segment of the S-amlodipine market. S-amlodipine is effectively used as monotherapy or in combination with other antihypertensive medications to control blood pressure and reduce the risk of associated complications such as heart attack, stroke, and kidney disease. Coronary artery disease (CAD), including stable angina and unstable angina, is another significant application area. S-amlodipine helps to improve blood flow to the heart muscle by dilating coronary arteries, thereby alleviating chest pain and reducing the risk of heart attacks. Other applications include the management of chronic stable angina, peripheral vascular disease, and certain types of heart failure. The growing prevalence of these cardiovascular conditions, coupled with the efficacy and safety profile of S-amlodipine, is driving its widespread use across these diverse applications.
The global S-amlodipine market exhibits diverse regional dynamics. North America and Europe currently dominate the market, driven by factors such as high prevalence of cardiovascular diseases, well-established healthcare systems, and early adoption of new therapies. These regions have mature healthcare infrastructures with a strong emphasis on preventive care and chronic disease management, leading to high demand for effective antihypertensive medications like S-amlodipine. The Asia-Pacific region is witnessing the most rapid growth, fueled by factors such as increasing urbanization, rising prevalence of cardiovascular diseases, and growing healthcare expenditure. Countries like China and India, with their large populations and rapidly aging demographics, are experiencing significant market expansion. Latin America, the Middle East, and Africa are emerging markets with significant growth potential, driven by improving healthcare infrastructure, increasing awareness of cardiovascular diseases, and rising disposable incomes. These regions are witnessing a growing demand for affordable and effective medications like S-amlodipine to address the rising burden of cardiovascular diseases.
Table of Contents
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global S-Amlodipine Annual Sales 2019-2030
- 2.1.2 World Current & Future Analysis for S-Amlodipine by Geographic Region, 2019, 2023 & 2030
- 2.1.3 World Current & Future Analysis for S-Amlodipine by Country/Region, 2019, 2023 & 2030
- 2.2 S-Amlodipine Segment by Type
- 2.2.1 Amlodipine Besylate Tablets
- 2.2.2 Amlodipine Mesylate Tablets
- 2.2.3 Amlodipine Maleate Tablets
- 2.3 S-Amlodipine Sales by Type
- 2.3.1 Global S-Amlodipine Sales Market Share by Type (2019-2024)
- 2.3.2 Global S-Amlodipine Revenue and Market Share by Type (2019-2024)
- 2.3.3 Global S-Amlodipine Sale Price by Type (2019-2024)
- 2.4 S-Amlodipine Segment by Application
- 2.4.1 Hypertension
- 2.4.2 Angina pectoris
- 2.5 S-Amlodipine Sales by Application
- 2.5.1 Global S-Amlodipine Sale Market Share by Application (2019-2024)
- 2.5.2 Global S-Amlodipine Revenue and Market Share by Application (2019-2024)
- 2.5.3 Global S-Amlodipine Sale Price by Application (2019-2024)
- 3 Global S-Amlodipine by Company
- 3.1 Global S-Amlodipine Breakdown Data by Company
- 3.1.1 Global S-Amlodipine Annual Sales by Company (2019-2024)
- 3.1.2 Global S-Amlodipine Sales Market Share by Company (2019-2024)
- 3.2 Global S-Amlodipine Annual Revenue by Company (2019-2024)
- 3.2.1 Global S-Amlodipine Revenue by Company (2019-2024)
- 3.2.2 Global S-Amlodipine Revenue Market Share by Company (2019-2024)
- 3.3 Global S-Amlodipine Sale Price by Company
- 3.4 Key Manufacturers S-Amlodipine Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers S-Amlodipine Product Location Distribution
- 3.4.2 Players S-Amlodipine Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
- 4 World Historic Review for S-Amlodipine by Geographic Region
- 4.1 World Historic S-Amlodipine Market Size by Geographic Region (2019-2024)
- 4.1.1 Global S-Amlodipine Annual Sales by Geographic Region (2019-2024)
- 4.1.2 Global S-Amlodipine Annual Revenue by Geographic Region (2019-2024)
- 4.2 World Historic S-Amlodipine Market Size by Country/Region (2019-2024)
- 4.2.1 Global S-Amlodipine Annual Sales by Country/Region (2019-2024)
- 4.2.2 Global S-Amlodipine Annual Revenue by Country/Region (2019-2024)
- 4.3 Americas S-Amlodipine Sales Growth
- 4.4 APAC S-Amlodipine Sales Growth
- 4.5 Europe S-Amlodipine Sales Growth
- 4.6 Middle East & Africa S-Amlodipine Sales Growth
- 5 Americas
- 5.1 Americas S-Amlodipine Sales by Country
- 5.1.1 Americas S-Amlodipine Sales by Country (2019-2024)
- 5.1.2 Americas S-Amlodipine Revenue by Country (2019-2024)
- 5.2 Americas S-Amlodipine Sales by Type
- 5.3 Americas S-Amlodipine Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC S-Amlodipine Sales by Region
- 6.1.1 APAC S-Amlodipine Sales by Region (2019-2024)
- 6.1.2 APAC S-Amlodipine Revenue by Region (2019-2024)
- 6.2 APAC S-Amlodipine Sales by Type
- 6.3 APAC S-Amlodipine Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
- 7 Europe
- 7.1 Europe S-Amlodipine by Country
- 7.1.1 Europe S-Amlodipine Sales by Country (2019-2024)
- 7.1.2 Europe S-Amlodipine Revenue by Country (2019-2024)
- 7.2 Europe S-Amlodipine Sales by Type
- 7.3 Europe S-Amlodipine Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa S-Amlodipine by Country
- 8.1.1 Middle East & Africa S-Amlodipine Sales by Country (2019-2024)
- 8.1.2 Middle East & Africa S-Amlodipine Revenue by Country (2019-2024)
- 8.2 Middle East & Africa S-Amlodipine Sales by Type
- 8.3 Middle East & Africa S-Amlodipine Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of S-Amlodipine
- 10.3 Manufacturing Process Analysis of S-Amlodipine
- 10.4 Industry Chain Structure of S-Amlodipine
- 11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 S-Amlodipine Distributors
- 11.3 S-Amlodipine Customer
- 12 World Forecast Review for S-Amlodipine by Geographic Region
- 12.1 Global S-Amlodipine Market Size Forecast by Region
- 12.1.1 Global S-Amlodipine Forecast by Region (2025-2030)
- 12.1.2 Global S-Amlodipine Annual Revenue Forecast by Region (2025-2030)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global S-Amlodipine Forecast by Type
- 12.7 Global S-Amlodipine Forecast by Application
- 13 Key Players Analysis
- 13.1 Aristo Pharmaceuticals Pvt Ltd
- 13.1.1 Aristo Pharmaceuticals Pvt Ltd Company Information
- 13.1.2 Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Product Portfolios and Specifications
- 13.1.3 Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.1.4 Aristo Pharmaceuticals Pvt Ltd Main Business Overview
- 13.1.5 Aristo Pharmaceuticals Pvt Ltd Latest Developments
- 13.2 Novartis
- 13.2.1 Novartis Company Information
- 13.2.2 Novartis S-Amlodipine Product Portfolios and Specifications
- 13.2.3 Novartis S-Amlodipine Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.2.4 Novartis Main Business Overview
- 13.2.5 Novartis Latest Developments
- 13.3 Pfizer
- 13.3.1 Pfizer Company Information
- 13.3.2 Pfizer S-Amlodipine Product Portfolios and Specifications
- 13.3.3 Pfizer S-Amlodipine Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.3.4 Pfizer Main Business Overview
- 13.3.5 Pfizer Latest Developments
- 13.4 Lek
- 13.4.1 Lek Company Information
- 13.4.2 Lek S-Amlodipine Product Portfolios and Specifications
- 13.4.3 Lek S-Amlodipine Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.4.4 Lek Main Business Overview
- 13.4.5 Lek Latest Developments
- 13.5 TEVA
- 13.5.1 TEVA Company Information
- 13.5.2 TEVA S-Amlodipine Product Portfolios and Specifications
- 13.5.3 TEVA S-Amlodipine Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.5.4 TEVA Main Business Overview
- 13.5.5 TEVA Latest Developments
- 13.6 Macleods Pharmaceuticals
- 13.6.1 Macleods Pharmaceuticals Company Information
- 13.6.2 Macleods Pharmaceuticals S-Amlodipine Product Portfolios and Specifications
- 13.6.3 Macleods Pharmaceuticals S-Amlodipine Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.6.4 Macleods Pharmaceuticals Main Business Overview
- 13.6.5 Macleods Pharmaceuticals Latest Developments
- 13.7 Caraco Pharmaceutical
- 13.7.1 Caraco Pharmaceutical Company Information
- 13.7.2 Caraco Pharmaceutical S-Amlodipine Product Portfolios and Specifications
- 13.7.3 Caraco Pharmaceutical S-Amlodipine Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.7.4 Caraco Pharmaceutical Main Business Overview
- 13.7.5 Caraco Pharmaceutical Latest Developments
- 13.8 Sanis Health
- 13.8.1 Sanis Health Company Information
- 13.8.2 Sanis Health S-Amlodipine Product Portfolios and Specifications
- 13.8.3 Sanis Health S-Amlodipine Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.8.4 Sanis Health Main Business Overview
- 13.8.5 Sanis Health Latest Developments
- 13.9 Jamp Pharma
- 13.9.1 Jamp Pharma Company Information
- 13.9.2 Jamp Pharma S-Amlodipine Product Portfolios and Specifications
- 13.9.3 Jamp Pharma S-Amlodipine Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.9.4 Jamp Pharma Main Business Overview
- 13.9.5 Jamp Pharma Latest Developments
- 13.10 Accel Pharma
- 13.10.1 Accel Pharma Company Information
- 13.10.2 Accel Pharma S-Amlodipine Product Portfolios and Specifications
- 13.10.3 Accel Pharma S-Amlodipine Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.10.4 Accel Pharma Main Business Overview
- 13.10.5 Accel Pharma Latest Developments
- 13.11 Jubilant Generics
- 13.11.1 Jubilant Generics Company Information
- 13.11.2 Jubilant Generics S-Amlodipine Product Portfolios and Specifications
- 13.11.3 Jubilant Generics S-Amlodipine Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.11.4 Jubilant Generics Main Business Overview
- 13.11.5 Jubilant Generics Latest Developments
- 13.12 Angita Pharma
- 13.12.1 Angita Pharma Company Information
- 13.12.2 Angita Pharma S-Amlodipine Product Portfolios and Specifications
- 13.12.3 Angita Pharma S-Amlodipine Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.12.4 Angita Pharma Main Business Overview
- 13.12.5 Angita Pharma Latest Developments
- 13.13 Florida DOH Central Pharmacy
- 13.13.1 Florida DOH Central Pharmacy Company Information
- 13.13.2 Florida DOH Central Pharmacy S-Amlodipine Product Portfolios and Specifications
- 13.13.3 Florida DOH Central Pharmacy S-Amlodipine Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.13.4 Florida DOH Central Pharmacy Main Business Overview
- 13.13.5 Florida DOH Central Pharmacy Latest Developments
- 13.14 Chengdu Di'ao Pharmaceutical Group Co., Ltd.
- 13.14.1 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Company Information
- 13.14.2 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Product Portfolios and Specifications
- 13.14.3 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.14.4 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Main Business Overview
- 13.14.5 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Latest Developments
- 13.15 Yangzijiang Pharmaceutical
- 13.15.1 Yangzijiang Pharmaceutical Company Information
- 13.15.2 Yangzijiang Pharmaceutical S-Amlodipine Product Portfolios and Specifications
- 13.15.3 Yangzijiang Pharmaceutical S-Amlodipine Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.15.4 Yangzijiang Pharmaceutical Main Business Overview
- 13.15.5 Yangzijiang Pharmaceutical Latest Developments
- 14 Research Findings and Conclusion
Table 1. S-Amlodipine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. S-Amlodipine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Amlodipine Besylate Tablets
Table 4. Major Players of Amlodipine Mesylate Tablets
Table 5. Major Players of Amlodipine Maleate Tablets
Table 6. Global S-Amlodipine Sales by Type (2019-2024) & (K Units)
Table 7. Global S-Amlodipine Sales Market Share by Type (2019-2024)
Table 8. Global S-Amlodipine Revenue by Type (2019-2024) & ($ million)
Table 9. Global S-Amlodipine Revenue Market Share by Type (2019-2024)
Table 10. Global S-Amlodipine Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global S-Amlodipine Sales by Application (2019-2024) & (K Units)
Table 12. Global S-Amlodipine Sales Market Share by Application (2019-2024)
Table 13. Global S-Amlodipine Revenue by Application (2019-2024)
Table 14. Global S-Amlodipine Revenue Market Share by Application (2019-2024)
Table 15. Global S-Amlodipine Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global S-Amlodipine Sales by Company (2019-2024) & (K Units)
Table 17. Global S-Amlodipine Sales Market Share by Company (2019-2024)
Table 18. Global S-Amlodipine Revenue by Company (2019-2024) ($ Millions)
Table 19. Global S-Amlodipine Revenue Market Share by Company (2019-2024)
Table 20. Global S-Amlodipine Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers S-Amlodipine Producing Area Distribution and Sales Area
Table 22. Players S-Amlodipine Products Offered
Table 23. S-Amlodipine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global S-Amlodipine Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global S-Amlodipine Sales Market Share Geographic Region (2019-2024)
Table 28. Global S-Amlodipine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global S-Amlodipine Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global S-Amlodipine Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global S-Amlodipine Sales Market Share by Country/Region (2019-2024)
Table 32. Global S-Amlodipine Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global S-Amlodipine Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas S-Amlodipine Sales by Country (2019-2024) & (K Units)
Table 35. Americas S-Amlodipine Sales Market Share by Country (2019-2024)
Table 36. Americas S-Amlodipine Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas S-Amlodipine Revenue Market Share by Country (2019-2024)
Table 38. Americas S-Amlodipine Sales by Type (2019-2024) & (K Units)
Table 39. Americas S-Amlodipine Sales by Application (2019-2024) & (K Units)
Table 40. APAC S-Amlodipine Sales by Region (2019-2024) & (K Units)
Table 41. APAC S-Amlodipine Sales Market Share by Region (2019-2024)
Table 42. APAC S-Amlodipine Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC S-Amlodipine Revenue Market Share by Region (2019-2024)
Table 44. APAC S-Amlodipine Sales by Type (2019-2024) & (K Units)
Table 45. APAC S-Amlodipine Sales by Application (2019-2024) & (K Units)
Table 46. Europe S-Amlodipine Sales by Country (2019-2024) & (K Units)
Table 47. Europe S-Amlodipine Sales Market Share by Country (2019-2024)
Table 48. Europe S-Amlodipine Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe S-Amlodipine Revenue Market Share by Country (2019-2024)
Table 50. Europe S-Amlodipine Sales by Type (2019-2024) & (K Units)
Table 51. Europe S-Amlodipine Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa S-Amlodipine Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa S-Amlodipine Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa S-Amlodipine Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa S-Amlodipine Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa S-Amlodipine Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa S-Amlodipine Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of S-Amlodipine
Table 59. Key Market Challenges & Risks of S-Amlodipine
Table 60. Key Industry Trends of S-Amlodipine
Table 61. S-Amlodipine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. S-Amlodipine Distributors List
Table 64. S-Amlodipine Customer List
Table 65. Global S-Amlodipine Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global S-Amlodipine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas S-Amlodipine Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas S-Amlodipine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC S-Amlodipine Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC S-Amlodipine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe S-Amlodipine Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe S-Amlodipine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa S-Amlodipine Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa S-Amlodipine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global S-Amlodipine Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global S-Amlodipine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global S-Amlodipine Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global S-Amlodipine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Aristo Pharmaceuticals Pvt Ltd Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 80. Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Product Portfolios and Specifications
Table 81. Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Aristo Pharmaceuticals Pvt Ltd Main Business
Table 83. Aristo Pharmaceuticals Pvt Ltd Latest Developments
Table 84. Novartis Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 85. Novartis S-Amlodipine Product Portfolios and Specifications
Table 86. Novartis S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Novartis Main Business
Table 88. Novartis Latest Developments
Table 89. Pfizer Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 90. Pfizer S-Amlodipine Product Portfolios and Specifications
Table 91. Pfizer S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Pfizer Main Business
Table 93. Pfizer Latest Developments
Table 94. Lek Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 95. Lek S-Amlodipine Product Portfolios and Specifications
Table 96. Lek S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Lek Main Business
Table 98. Lek Latest Developments
Table 99. TEVA Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 100. TEVA S-Amlodipine Product Portfolios and Specifications
Table 101. TEVA S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. TEVA Main Business
Table 103. TEVA Latest Developments
Table 104. Macleods Pharmaceuticals Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 105. Macleods Pharmaceuticals S-Amlodipine Product Portfolios and Specifications
Table 106. Macleods Pharmaceuticals S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. Macleods Pharmaceuticals Main Business
Table 108. Macleods Pharmaceuticals Latest Developments
Table 109. Caraco Pharmaceutical Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 110. Caraco Pharmaceutical S-Amlodipine Product Portfolios and Specifications
Table 111. Caraco Pharmaceutical S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. Caraco Pharmaceutical Main Business
Table 113. Caraco Pharmaceutical Latest Developments
Table 114. Sanis Health Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 115. Sanis Health S-Amlodipine Product Portfolios and Specifications
Table 116. Sanis Health S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. Sanis Health Main Business
Table 118. Sanis Health Latest Developments
Table 119. Jamp Pharma Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 120. Jamp Pharma S-Amlodipine Product Portfolios and Specifications
Table 121. Jamp Pharma S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Jamp Pharma Main Business
Table 123. Jamp Pharma Latest Developments
Table 124. Accel Pharma Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 125. Accel Pharma S-Amlodipine Product Portfolios and Specifications
Table 126. Accel Pharma S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. Accel Pharma Main Business
Table 128. Accel Pharma Latest Developments
Table 129. Jubilant Generics Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 130. Jubilant Generics S-Amlodipine Product Portfolios and Specifications
Table 131. Jubilant Generics S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 132. Jubilant Generics Main Business
Table 133. Jubilant Generics Latest Developments
Table 134. Angita Pharma Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 135. Angita Pharma S-Amlodipine Product Portfolios and Specifications
Table 136. Angita Pharma S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 137. Angita Pharma Main Business
Table 138. Angita Pharma Latest Developments
Table 139. Florida DOH Central Pharmacy Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 140. Florida DOH Central Pharmacy S-Amlodipine Product Portfolios and Specifications
Table 141. Florida DOH Central Pharmacy S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 142. Florida DOH Central Pharmacy Main Business
Table 143. Florida DOH Central Pharmacy Latest Developments
Table 144. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 145. Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Product Portfolios and Specifications
Table 146. Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 147. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Main Business
Table 148. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Latest Developments
Table 149. Yangzijiang Pharmaceutical Basic Information, S-Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 150. Yangzijiang Pharmaceutical S-Amlodipine Product Portfolios and Specifications
Table 151. Yangzijiang Pharmaceutical S-Amlodipine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 152. Yangzijiang Pharmaceutical Main Business
Table 153. Yangzijiang Pharmaceutical Latest Developments
List of
Figure 1. Picture of S-Amlodipine
Figure 2. S-Amlodipine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global S-Amlodipine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global S-Amlodipine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. S-Amlodipine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Amlodipine Besylate Tablets
Figure 10. Product Picture of Amlodipine Mesylate Tablets
Figure 11. Product Picture of Amlodipine Maleate Tablets
Figure 12. Global S-Amlodipine Sales Market Share by Type in 2023
Figure 13. Global S-Amlodipine Revenue Market Share by Type (2019-2024)
Figure 14. S-Amlodipine Consumed in Hypertension
Figure 15. Global S-Amlodipine Market: Hypertension (2019-2024) & (K Units)
Figure 16. S-Amlodipine Consumed in Angina pectoris
Figure 17. Global S-Amlodipine Market: Angina pectoris (2019-2024) & (K Units)
Figure 18. Global S-Amlodipine Sales Market Share by Application (2023)
Figure 19. Global S-Amlodipine Revenue Market Share by Application in 2023
Figure 20. S-Amlodipine Sales Market by Company in 2023 (K Units)
Figure 21. Global S-Amlodipine Sales Market Share by Company in 2023
Figure 22. S-Amlodipine Revenue Market by Company in 2023 ($ Million)
Figure 23. Global S-Amlodipine Revenue Market Share by Company in 2023
Figure 24. Global S-Amlodipine Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global S-Amlodipine Revenue Market Share by Geographic Region in 2023
Figure 26. Americas S-Amlodipine Sales 2019-2024 (K Units)
Figure 27. Americas S-Amlodipine Revenue 2019-2024 ($ Millions)
Figure 28. APAC S-Amlodipine Sales 2019-2024 (K Units)
Figure 29. APAC S-Amlodipine Revenue 2019-2024 ($ Millions)
Figure 30. Europe S-Amlodipine Sales 2019-2024 (K Units)
Figure 31. Europe S-Amlodipine Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa S-Amlodipine Sales 2019-2024 (K Units)
Figure 33. Middle East & Africa S-Amlodipine Revenue 2019-2024 ($ Millions)
Figure 34. Americas S-Amlodipine Sales Market Share by Country in 2023
Figure 35. Americas S-Amlodipine Revenue Market Share by Country in 2023
Figure 36. Americas S-Amlodipine Sales Market Share by Type (2019-2024)
Figure 37. Americas S-Amlodipine Sales Market Share by Application (2019-2024)
Figure 38. United States S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC S-Amlodipine Sales Market Share by Region in 2023
Figure 43. APAC S-Amlodipine Revenue Market Share by Regions in 2023
Figure 44. APAC S-Amlodipine Sales Market Share by Type (2019-2024)
Figure 45. APAC S-Amlodipine Sales Market Share by Application (2019-2024)
Figure 46. China S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 50. India S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe S-Amlodipine Sales Market Share by Country in 2023
Figure 54. Europe S-Amlodipine Revenue Market Share by Country in 2023
Figure 55. Europe S-Amlodipine Sales Market Share by Type (2019-2024)
Figure 56. Europe S-Amlodipine Sales Market Share by Application (2019-2024)
Figure 57. Germany S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 58. France S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa S-Amlodipine Sales Market Share by Country in 2023
Figure 63. Middle East & Africa S-Amlodipine Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa S-Amlodipine Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa S-Amlodipine Sales Market Share by Application (2019-2024)
Figure 66. Egypt S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country S-Amlodipine Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of S-Amlodipine in 2023
Figure 72. Manufacturing Process Analysis of S-Amlodipine
Figure 73. Industry Chain Structure of S-Amlodipine
Figure 74. Channels of Distribution
Figure 75. Global S-Amlodipine Sales Market Forecast by Region (2025-2030)
Figure 76. Global S-Amlodipine Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global S-Amlodipine Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global S-Amlodipine Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global S-Amlodipine Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global S-Amlodipine Revenue Market Share Forecast by Application (2025-2030)
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (03 June, 2026)
- Notify To Team (03 June, 2026)
- Report updation (04 June, 2026)
- Report Quality Check (04 June, 2026)
- Report Dispatch (05 June, 2026)
- Hard Copy
Recently Viewed Products
Global S-Amlodipine Market Growth 2024-2030
We are friendly and approachable, give us a call.